申请人:Snyder John K.
公开号:US20130065875A1
公开(公告)日:2013-03-14
The invention provides derivatives and analogues of triazatetracyclo[7.7.0.0
1,13
,0
2,7
]-hexadeca-2,4,6,10,12-pentaenes, 5,7,11-triazatetracyclo[8.7.0.0
1,6
,0
12,17
]-heptadeca-6,8,12,14,16-pentaenes, pharmaceutical compositions comprising these compounds and methods for treatment of hepatitis C viral infections using these compounds.